The role of peginterferon in nucleos(t)ide-analogue-treated chronic hepatitis B patients: A review of published literature.

about

The role of peginterferon in nucleos(t)ide-analogue-treated chronic hepatitis B patients: A review of published literature.

Item

http://www.wikidata.org/entity/Q39140348

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

The role of peginterferon in nucleos

@nl

The role of peginterferon in n ...... eview of published literature.

@en

type

Item

label

The role of peginterferon in nucleos

@nl

The role of peginterferon in n ...... eview of published literature.

@en

prefLabel

The role of peginterferon in nucleos

@nl

The role of peginterferon in n ...... eview of published literature.

@en

P1476

The role of peginterferon in n ...... eview of published literature.

@en

P2093

H Ren

http://www.w3.org/2001/XMLSchema#string

J Jia

http://www.w3.org/2001/XMLSchema#string

Q Ning

http://www.w3.org/2001/XMLSchema#string

Q Xie

http://www.w3.org/2001/XMLSchema#string

W Zhang

http://www.w3.org/2001/XMLSchema#string

X Chen

http://www.w3.org/2001/XMLSchema#string

X Dou

http://www.w3.org/2001/XMLSchema#string

Y Xie

http://www.w3.org/2001/XMLSchema#string

P2860

Hepatitis B virus: inactive carriers

Current and future directions for treating hepatitis B virus infection

Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial

EASL clinical practice guidelines: Management of chronic hepatitis B virus infection

Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.

Impact of a new reimbursement program on hepatitis B antiviral medication cost and utilization in Beijing, China

AASLD guidelines for treatment of chronic hepatitis B.

Flares in chronic hepatitis B patients induced by the host or the virus? Relation to treatment response during Peg-interferon {alpha}-2b therapy.

Sequential combination therapy with pegylated interferon leads to loss of hepatitis B surface antigen and hepatitis B e antigen (HBeAg) seroconversion in HBeAg-positive chronic hepatitis B patients receiving long-term entecavir treatment.

Off-treatment durability of antiviral response to nucleoside analogues in patients with chronic hepatitis B

P304

618-623

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/JVH.12695

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-02-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28211135

http://www.w3.org/2001/XMLSchema#string